Home > Balance Sheet > BETA DRUGS

BETA DRUGS
Total Non-Current Liabilities

    Back to Balance Sheet
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹135 Cr₹11 Cr₹11 Cr₹16 Cr₹15 Cr

What is the latest Total Non-Current Liabilities ratio of BETA DRUGS ?

The latest Total Non-Current Liabilities ratio of BETA DRUGS is ₹135 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹135 Cr
Mar2024₹11 Cr
Mar2023₹11 Cr
Mar2022₹16 Cr
Mar2021₹15 Cr

How is Total Non-Current Liabilities of BETA DRUGS Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹135 Cr
1,134.46
Mar2024 ₹11 Cr
-3.70
Mar2023 ₹11 Cr
-28.62
Mar2022 ₹16 Cr
6.11
Mar2021 ₹15 Cr -

Compare Total Non-Current Liabilities of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,375.2 Cr 0.1% -14.5% 13.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,339.0 Cr -2.7% -3.7% 20.3% Stock Analytics
DIVIS LABORATORIES ₹254,068.0 Cr 3.7% 15.7% 51% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,767.0 Cr -0.8% 1% 36.2% Stock Analytics
CIPLA ₹111,804.0 Cr -2.1% -5.2% -11.6% Stock Analytics
DR REDDYS LABORATORIES ₹96,113.4 Cr -0.8% -0.5% -9.3% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

0.1%

-14.5%

13.2%

SENSEX

-1.8%

-3.7%

-5.7%


You may also like the below Video Courses